Skip to content

Now I'll perform a detailed review of the GO-CAM model gomodel:633b013300000089 based on the information gathered:

Review of GO-CAM model: 633b013300000089

Model Overview

Title: "Positive regulation of insulin secretion 11 (Mouse)"
Taxon: Mouse (NCBITaxon:10090)
Status: Production

Model Content Evaluation

This model represents a G protein-coupled receptor (GPCR) signaling pathway that leads to calcium channel activation, which is involved in the regulation of insulin secretion. The pathway begins with the FFAR2 receptor (MGI:MGI:2441731), which when activated, signals through G-proteins (Gna11 and Gnaq), leading to activation of phospholipase C beta 1 (Plcb1), which in turn activates the IP3 receptor (Itpr1).

Strengths:

  1. The model correctly represents the causal flow of a GPCR signaling pathway, with appropriate "directly positively regulates" (RO:0002629) relationships between activities.

  2. The model correctly indicates cellular locations, with activities occurring at the plasma membrane (GO:0005886).

  3. The biological process context is consistently annotated for each activity as "phospholipase C-activating G protein-coupled receptor signaling pathway" (GO:0007200).

  4. The input/output molecules for phospholipase C activity are properly annotated (PIP2 → DAG + IP3).

  5. The evidence for each activity is appropriately referenced with PMIDs and evidence codes.

Issues Identified:

  1. Missing Small Molecule Ligand: While the model implies that the FFAR2 receptor is activated by acetate (according to the literature), the small molecule activator is not explicitly represented in the model. According to the "Signaling receptor activity annotation guidelines", small molecule activators should be linked to the receptor activity with the relation "is small molecule activator".

  2. Incomplete Pathway Context: The model title mentions "Positive regulation of insulin secretion", but there's no explicit connection to insulin secretion (GO:0030073) in the model. The pathway ends with the IP3 receptor activity without showing how this leads to insulin secretion.

  3. Cellular Context: There's no indication that these activities occur in pancreatic beta cells (CL:0000169), which would be important for the proper contextual understanding of insulin secretion.

  4. Missing Final Output: The model doesn't show how IP3 receptor activation leads to calcium release and ultimately insulin secretion, leaving the pathway incomplete.

  5. FFAR2 Receptor Input/Target: According to the "Signaling receptor activity annotation guidelines", the receptor's target should be the effector protein it regulates (G-proteins in this case), which should be captured with a 'has input' relation. This relationship appears to be missing.

Recommendations

  1. Add Small Molecule Activator: Connect acetate (CHEBI:30089) to the FFAR2 receptor activity using the "is small molecule activator" relation.

  2. Complete the Pathway: Add the downstream activities showing how IP3 receptor activation leads to calcium release, which then triggers insulin secretion.

  3. Add Cellular Context: Explicitly annotate that these activities occur in pancreatic beta cells (CL:0000169).

  4. Add FFAR2 Receptor Input: Add the 'has input' relation from the FFAR2 receptor to its G-protein targets.

  5. Connect to Insulin Secretion: Add activities that connect the IP3 receptor to insulin secretion (GO:0030073) to complete the biological process context.

Summary

The model gomodel:633b013300000089 presents a well-structured GPCR signaling pathway that leads to IP3 receptor activation. It correctly represents the molecular activities and their relationships in the pathway. However, the model could be improved by adding the small molecule activator, including the complete pathway to insulin secretion, and providing the cellular context of pancreatic beta cells. With these additions, the model would better represent the biological process of positive regulation of insulin secretion mediated by FFAR2 in mice.